The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: A review of instruments to assess Crohn's disease

Canadian Journal of Gastroenterology

Volumn 13, Issue 1, 1999, Pages 65-73

  Yoshida, Eric M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Cape Town Index; Crohn's Disease Activity Index; Harvey Bradshaw Index; Inflammatory Bowel Disease Questionnaire; Reliability; Validity; Van Hees Index

Indexed keywords

CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; EMOTION; ENTERITIS; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SOCIAL BEHAVIOR;

EID: 0032897042     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/506915     Document Type: Review

References (47)

1. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-507.
2. Ogorek CP, Fisher RS. Differentiation between Crohn's disease and ulcerative colitis. Med Clin North Am 1994;78:1249-58.
3. Levine JB, Lukawski-Trubish D. Extraintestinal considerations in inflammatory bowel disease. Gastroenterol Clin North Am 1995:24:633-46.
4. Winship DH, Summers RW, Singleton JW, et al. National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology 1979;77:829-42.
5. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-44.
6. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979;77:847-69.
7. Singleton JW, Summers RW, Kern F Jr, et al. A trial of sulfasalazine as adjunctive therapy in Crohn's disease. Gastroenterology 1979;77:887-97.
8. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994;331:836-41.
9. Rutgeerts P, Lofgerg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994;331:842-5.
10. Feagan BG, McDonald JWD, Rochon J, et al. Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med 1994;330:1846-51.
11. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
12. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease CA2 Study Group. N Engl J Med 1997;337:1029-35.
13. Stack WA, Mann SD, Roy AJ, et al. Randomized controlled trial of CDP571 antibody to tumor necrosis factor-alpha in Crohn's disease. Lancet 1997;349:521-4.
14. Willoughby JMT, Beckett J, Kumar PJ, Dawson AM. Controlled trial of azathioprine in Crohn's disease. Lancet 1971;ii:944-7.
15. Streiner DL, Norman GR. Devising the items. In: Health Measurement Scales. A Practical Guide to their Development and Use, 2nd edn. New York: Oxford University Press, 1995:16-27.
16. Pagano M, Gauvreau K. Multiple regression. In: Principles of Biostatistics. Belmont: Duxbury Press, 1992:409-25.
17. Streiner DL, Norman GR. Reliability. In: Health Measurement Scales. A Practical Guide to their Development and Use, 2nd edn. New York: Oxford University Press, 1995:104-27.
18. Sackett DL. Clinical disagreement: I. How often it occurs and why. Can Med Assoc J 1980;20:499-504.
19. Ker M. Issues in the use of kappa. Invest Radiol 1991;26:78-83.
20. Colton T. Regression and correlation. In: Statistics in Medicine. Boston: Little Brown and Company, 1974:189-917.
21. Sandler RS, Jordan MD, Kupper LL. Development of a Crohn's index for survey research. J Clin Epidemiol 1988;41:451-8.
22. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979;77:843-6.
23. Selvin S. General concepts. In: Practical Biostatistical Methods. Belmont: Duxbury Press, 1995:1-30.
24. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994;106:287-96.
25. De Dombal FT, Softley A. IOIBD report no 1: observer variation in calculating indices of severity and activity in Crohn's disease. Gut 1987;28:474-81.
26. Streiner DL, Norman GR. Validity. In: Health Measurement Scales. A Practical Guide to their Development and Use, 2nd edn. New York: Oxford University Press, 1995:144-62.
27. Harms HK, Blomer R, Bertele-Harms RM, et al. A paediatric Crohn's disease activity index (PCDAI). Is it useful? Acta Paediatr 1994;395(Suppl):22-6.
28. Garrett JW, Drossman DA. Health status in inflammatory bowel disease. Gastroenterology 1990;99:90-6.
29. Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986;27:92-5.
30. 111indium autologous mixed leucocyte scanning accurately assess disease extent and activity in Crohn's disease? Gut 1988;29:821-5.
31. Crama-Bohbouth G, Pena AS, Biemond I, et al. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease? Gut 1989;30:1236-40.
32. Saverymuttu SH, Peters AM, Lavender JP, et al. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology 1983;85:1333-9.
33. Giaffer MH, Tindale WB, Senior S, et al. Quantification of disease activity in Crohn's disease by computer analysis of Tc-99m hexamethyl propylene amine oxime (HMPAO) labelled leucocyte images. Gut 1993;34:68-74.
34. Acciuffi S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment Pharmacol Ther 1996;10:321-6.
35. Wright JP, Young GO, Tigler-Wybrandi N. Predictors of acute relapse of Crohn's disease. A laboratory and clinical study. Dig Dis Sci 1987;32:164-70.
36. Mee AS, Brown DJ, Jewell DP. Crohn's disease activity index - is it useful? Gut 1978;19:A990.
37. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;i:514.
38. Wright JP, Marks IN, Parfitt A. A simple clinical index of Crohn's disease activity - the Cape Town index. S Afr Med J 1985;68:502-3.
39. Andre C, Descos L, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 1981;22:571-4.
40. Cooke WT, Prior P. Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol 1984;6:17-25.
41. Van Hees PAM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980;21:279-86.
42. Drossman DA, Patrick DL, Mitchell CM, et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379-86.
43. Mitchell A, Guyatt G, Singer J, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988;10:306-10.
44. Guyatt GH, Deyo RA, Charlson M, et al. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989;42:403-8.
45. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10.
46. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992;14:15-9.
47. Powell-Tuck J, Brown RL, Lennard-Jones JE. A comparison of oral prednisone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978;13:833-7.